🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next up, check out #URO92 with Sia Daneshmand, M.D. to review the modern management of stage 2 seminoma Testicular Cancer Testicular Cancer Society #testicularcancerawarenessmonth open.spotify.com/episode/6PmVV5…

Was putting the dishes away this morning & listened to the most amazing podcast w Nishant Patel, MD on BackTable Urology (hosted by DrBagrodia UCSD Urology). All I can say is THANK YOU Nishant for putting such a personal story out there. I’m sure it’s going to be beneficial for many

1/ Has there been an improvement in surgical overtreatment of prostate cancer over the past 2 decades? Yes — and profoundly. In 2010, 1 in 3 prostatectomies 🔪 were for indolent disease. In 2024, it's 1 in 20. Read our work below, presented at #AUA2025 today. 🧵

Stellar project led by Steven Monda and Tudor Borza at Michigan Urology, highlighting PC overtreatment trends using state-wide and nation-wide data. 🔵 Overall declining frequency of surgical tx for PC resulting in pGG1 disease. 🔵 Cases resulting in pGG1 are more likely to

So proud of Lina Posada and Mark Dawideks best poster win at #AUA2025 for their work on mechanism of outstanding response to immunotherapy in RCC! Memorial Sloan Kettering Cancer Center UrologyMSK

Salvador Jaime-Casas, MD Sumanta K. Pal, MD, FASCO Wesley Yip Abhishek Tripathi We would like to inform you that your post has been published on OncoDaily.com. Thank you for sharing! oncodaily.com/science/sumant…

Wrapping up with the last MIBC session at Amer. Urol. Assn. AUA 25! Boris Gershman BIDMCUrology

Forever grateful to have been mentored by Zachery Reichert, MD, PhD and the UMich team on this project!

Huge congrats to our City of Hope star faculty Aditya Shreenivas MD MS who presented the phase III AK105-304 study in an oral session at #AACR25, a study leading to U.S. FDA approval of penpulimab-kcqx in #nasopharyngeal cancer!

Trends in Surgical Overtreatment of Prostate Cancer jamanetwork.com/journals/jamao… This retrospective cohort study assessed trends in the pathological grade of prostate cancer on prostatectomy specimens over the past two decades to evaluate overtreatment patterns. Using data from SEER

It’s been a minute! Good morning Chicago ☀️ I will be at AACR today presenting our work on CD5 cells and IO response. If you are interested in learning more, join me at Section 32/Board 26 (9-12AM PST). Appreciate the support of Sumanta K. Pal, MD, FASCO who made this possible and Marcin Kortylewski🇵🇱🇺🇦

#AACR25 In our study high baseline CD5 B cells linked to worse outcomes in mRCC patients treated with cabo/nivo. ➡️CD5+ B cells may be a prognostic biomarker—and potential target—for ICB response Thank you Sumanta K. Pal, MD, FASCO Marcin Kortylewski🇵🇱🇺🇦 Hedyeh Ebrahimi and Marice Alcantara, PhD!

Had a chance to celebrate Alex Chehrazi-Raffle, MD's new paper in ESMO Open (co-first auth: Miguel Zugman) over lunch today at SWOG Cancer Research Network! This multicenter collaboration exploring HDCT regimens (CE/TICE) required years of effort in which he pooled data across City of Hope, UCSF Helen Diller Family Comprehensive Cancer Ctr, USC Norris Comprehensive Cancer Center &

🚨Check out our multicenter study that compared the most commonly used high-dose chemo regimens for refractory #GCT. HUGE thanks to our collaborators at UCSF Helen Diller Family Comprehensive Cancer Ctr UC Davis Health UCLA Jonsson Comprehensive Cancer Center, and Miguel Zugman Sumanta K. Pal, MD, FASCO Tanya Dorff Matthew Mei for their leadership & support! 🙏🏼

Finished my internal medicine Sub-Internship at Mayo Clinic. Thankful for my incredible medical team Dr. Colbenson, Dr. Victor Rodríguez, Dr. Vijay, Dr. Emma and Dr. Nissiya. Glad to learn from all and to have met Aldo A Acosta Medina. Hope to be back soon Mayo Clinic Internal Medicine Residency Rochester #mayoclinic

Big congrats to my friend José Manuel Moreno-Mirón on wrapping up his sub-I at Mayo Clinic ! Always inspired by his hard work and drive. He is a rising star and future #internalmedicine applicant to watch in the coming years! #MedTwitter IMG_stories Project IMG ™

1/ Huge thanks to all collaborators, but especially to Alex Chehrazi-Raffle, MD , great friend and mentor, for the opportunity to contribute to this multicenter study on HDCT in refractory/recurrent #GCT!

What is the evidence for resection in metastatic RCC? Read our mini-review in Eur Urol Focus TLDR; see Figure 1- below. sciencedirect.com/science/articl… Udit Singhal, MD Simpa Salami Todd 〽️ Morgan, MD Ulka Vaishampayan

In SWOG Cancer Research Network 1605, utDNA (UroAmp) predicted response to Atezo in BCG-u #bladdercancer. Baseline and 3 mo positivity linked to lower CR and EFS. A step toward biomarkers-driven bladder sparing care. Marie-Pier St-Laurent Peter Black Parminder singh